Promis Neurosciences Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Promis Neurosciences Inc with three other
miscellaneous service companies in North America:
Medixall Group Inc
of the United States
(2018
sales of $1,858.00
),
AngioSoma Inc
of the United States
($890.00
), and
Tauriga Sciences Inc
(1,522.71 Canadian Dollars [US$1,149.22 ]
).
Sales Analysis.
Sales fell dramatically in 2018:
Promis Neurosciences Inc reported sales of C$475.00 (US$358.49)
for the
year ending
December of 2018.
This
represents
a
sharp
decrease of 95.2%
versus 2017, when the company's sales were C$9,895.00 .